U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
8088180881Safety and Tolerability of Liraglutide in Healthy Volunteers and Subjects With Type 2 DiabetesCompletedNo Results AvailableDiabetes|Diabetes Mellitus, Type 2|HealthyDrug: liraglutide|Drug: placebohttps://ClinicalTrials.gov/show/NCT01507285
8088280882Safety and Tolerability of Liraglutide in Healthy Male VolunteersCompletedNo Results AvailableDiabetes|HealthyDrug: liraglutide|Drug: liraglutide|Drug: placebo|Drug: placebohttps://ClinicalTrials.gov/show/NCT01507272
8088380883Chocolate's Effect on the Cerebral VasculatureCompletedNo Results AvailableCerebral VasculatureOther: cocoahttps://ClinicalTrials.gov/show/NCT01507259
8088480884Adult Patients Undergoing Open Colectomy MA402S23B303CompletedHas ResultsBowel ObstructionDrug: IV morphine sulfate|Drug: EXPAREL (bupivacaine liposome injectable suspension)https://ClinicalTrials.gov/show/NCT01507246
8088580885A Health Economic Trial in Adult Patients Undergoing Open Colectomy MA402S23B302TerminatedHas ResultsBowel ObstructionDrug: IV morphine sulfate|Drug: EXPAREL (bupivacaine liposome injectable suspension)https://ClinicalTrials.gov/show/NCT01507233
8088680886A Health Economic Trial in Adult Patients Undergoing Open Colectomy MA402S23B301TerminatedHas ResultsBowel ObstructionDrug: morphine sulfate|Drug: bupivacaine liposome extended-release injectable suspensionhttps://ClinicalTrials.gov/show/NCT01507220
8088780887Pediatric Dysphagia Outcomes After Injection Laryngoplasty for Type I Laryngeal CleftRecruitingNo Results AvailableDysphagia|Aspiration|Quality of LifeProcedure: Injection laryngoplastyhttps://ClinicalTrials.gov/show/NCT01507207
8088880888A Study of Vestipitant (GW597599) in the Treatment of Breakthrough Postoperative Nausea and Vomiting (PONV)CompletedNo Results AvailablePostoperative Nausea and VomitingDrug: Ondansetron|Drug: Vestipitanthttps://ClinicalTrials.gov/show/NCT01507194
8088980889Ketamine For Suicidal IdeationCompletedNo Results AvailableSuicidal IdeationDrug: Ketamine|Drug: Midazolamhttps://ClinicalTrials.gov/show/NCT01507181
8089080890A Study of RO5137382 (GC33) in Patients With Advanced or Metastatic Hepatocellular CarcinomaCompletedNo Results AvailableLiver CancerDrug: RO5137382|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01507168
8089180891An Open Label Study of Clinical Utility and Patient Outcomes of the Genecept AssayCompletedNo Results AvailableTreatment Resistant Depression|Generalized Anxiety DisorderDevice: Genecept Assayhttps://ClinicalTrials.gov/show/NCT01507155
8089280892Rapid Oral Test for Therapeutic Response in HIV/AIDS PatientsRecruitingNo Results AvailableAIDS/HIV PROBLEMhttps://ClinicalTrials.gov/show/NCT01507142
8089380893Biomarkers for Noninvasive Assessment of Human HydrationCompletedNo Results AvailableDehydrationhttps://ClinicalTrials.gov/show/NCT01507129
8089480894Diabetes Attitudes Wishes and NeedsCompletedNo Results AvailableDiabetes|Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2|Relatives to/Carers of Patients|Healthcare ProfessionalsOther: No treatment givenhttps://ClinicalTrials.gov/show/NCT01507116
8089580895Tecemotide (L-BLP25) in Rectal CancerCompletedNo Results AvailableRectal CancerBiological: Tecemotide (L-BLP25)|Drug: cyclophosphamide (CPA)|Other: Chemoradiotherapyhttps://ClinicalTrials.gov/show/NCT01507103
8089680896Validation of the Mercy TAPECompletedHas ResultsWeightDevice: Mercy TAPEhttps://ClinicalTrials.gov/show/NCT01507090
8089780897ZGN-440 (Beloranib for Subcutaneous Injection) for Treatment of ObesityCompletedNo Results AvailableObesityDrug: ZGN-440|Drug: ZGN-440 sterile diluenthttps://ClinicalTrials.gov/show/NCT01507077
8089880898Neoadjuvant Sorafenib Therapy Prior to Laser Ablation for Hepatocellular CarcinomaRecruitingNo Results AvailableHepatocellular CarcinomaDrug: Sorafenib|Procedure: laser ablation (LA)https://ClinicalTrials.gov/show/NCT01507064
8089980899Switching Study From Warfarin to RivaroxabanCompletedHas ResultsVenous ThrombosisDrug: Warfarin (Coumadin)|Drug: Rivaroxaban (Xarelto, BAY59-7939)|Drug: Placebo|Drug: Vitamin K (Konakion)https://ClinicalTrials.gov/show/NCT01507051
8090080900Safety and Efficacy of YH14617 in Diabetes MellitusCompletedNo Results AvailableDiabetes MellitusDrug: YH14617|Drug: YH14617|Drug: YH14617|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01507038
8090180901The Effect of Hinge Location on Corneal Sensation and Dry Eye After LASIK: A Systematic Review and Meta-analysisCompletedNo Results AvailableDry Eyehttps://ClinicalTrials.gov/show/NCT01507025
8090280902The Effect Of Berry Polyphenols On Human BehaviourCompletedNo Results AvailableHealthyDietary Supplement: Berry Polyphenols|Dietary Supplement: Placebohttps://ClinicalTrials.gov/show/NCT01507012
8090380903Genetic Mapping for Cardiac Risk AssessmentRecruitingNo Results AvailableAngina Pectoris|Myocardial Infarction|Coronary Disease|Myocardial Ischemia|Acute Coronary SyndromeBiological: MULTIGENE SCREENING FOR SINGLE SNPShttps://ClinicalTrials.gov/show/NCT01506999
8090480904Helicobacter Eradication Aspirin TrialRecruitingNo Results AvailableGastrointestinal Ulcer Haemorrhage|Bacterial Infection Due to Helicobacter Pylori (H. Pylori)Drug: Lansoprazole 30mg, Clarithromycin 500mg, Metronidazole 400mg|Drug: Placebo lansoprazole 30mg, clarithromycin 500mg, metronidazole 400mghttps://ClinicalTrials.gov/show/NCT01506986
8090580905A Phase I/II/Pharmacodynamic Study of Hydroxychloroquine in Combination With Gemcitabine/Abraxane to Inhibit Autophagy in Pancreatic CancerRecruitingNo Results AvailableAdvanced Adenocarcinoma|Metastatic AdenocarcinomaDrug: Hydroxychloroquine (HCQ)|Drug: Gemcitabinehttps://ClinicalTrials.gov/show/NCT01506973
8090680906Evaluation of a Combined Near Infrared Spectroscopy (NIRS) and Intravascular Ultrasound (IVUS) Catheter for Detection of Lipid Rich PlaqueTerminatedHas ResultsCoronary Artery DiseaseDevice: InfraReDx Lipiscan IVUShttps://ClinicalTrials.gov/show/NCT01506960
8090780907A Prospective Open-Label, Non-randomised, Single-arm, Pilot Clinical Study Evaluating the Effect of PTH Lowering On Erythropoietin Consumption in Calcitriol-Resistant PatientsActive, not recruitingNo Results AvailableModerate to Severe Secondary Hyperparathyroidism|Stage 5 Chronic Kidney DiseasesDrug: Paricalcitolhttps://ClinicalTrials.gov/show/NCT01506947
8090880908A Study Evaluating the Bioavailability of Two Formulations of Linifanib and Food Effect on Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid TumorsTerminatedNo Results AvailableAdvanced or Metastatic Solid TumorsDrug: linifanibhttps://ClinicalTrials.gov/show/NCT01506934
8090980909Racemic Ketamine Versus S-ketamine With Arterial Spin Labeling (ASL)-MRI in Healthy VolunteersCompletedNo Results AvailableHealthy|Abnormal Vascular FlowDrug: Racemic ketamine|Drug: S-ketaminehttps://ClinicalTrials.gov/show/NCT01506921
8091080910Provoked Craving AssessmentCompletedHas ResultsSmoking Dependence|SmokingDrug: oral nicotine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01506908

* Görseller ve İçerik tekif hakkına sahip olabilir